希腊IPF患者中IPF-PROM量表的应用及其与抑郁症状和健康相关生活质量的关系
该研究在希腊两家大学医院对136例IPF患者进行横断面观察,验证希腊版IPF-PROM量表,并分析其与PHQ-9抑郁症状及SF-12健康相关生活质量的关系。结果显示,IPF-PROM评估为重度症状的患者抑郁症状更高、生理与心理健康生活质量更低;氧饱和度升高与IPF-PROM评估为重度健康状态的比值比降低相关。
要点
- IPF-PROM可用于自报IPF患者生理与心理状态,并与抑郁症状和健康相关生活质量相关。
- IPF-PROM重度症状患者PHQ-9评分更高、SF-12生理与心理健康评分更低。
- 氧饱和度升高与IPF-PROM评估为重度健康状态的比值比降低相关。
核心结论
- 希腊版IPF-PROM可用于评估IPF患者健康状态,并与抑郁症状及健康相关生活质量相关,对临床和研究有潜在用途。
研究设计与样本
- 研究为两中心、观察性、横断面研究,纳入136例IPF患者(87.9%为男性),平均年龄73.5±7.9岁。
- 患者于2023–2024年在希腊两家大学医院的IPF门诊完成IPF-PROM、PHQ-9和SF-12量表。
主要发现
- IPF-PROM平均评分为41.7±31.3,患者总体被归类为中度疾病,其中呼吸困难/疲劳组合成分与心理幸福感成分分别为40.1和43.8(p>0.050)。
- IPF-PROM评估为重度症状者的PHQ-9抑郁症状评分高于中度与轻度者(分别为17.1、12.3和1.4,p<0.001)。
- IPF-PROM重度症状者的SF-12生理健康评分低于中度与轻度者(分别为32.6、34.7和47.9,p<0.001)。
- IPF-PROM重度症状者的SF-12心理健康评分低于中度与轻度者(分别为23.9、34.5和50.3,p<0.001)。
- 氧饱和度递增的患者按IPF-PROM评估为重度健康状态的比值比更低(OR=0.83,p=0.018)。
临床怎么用
- 在IPF门诊可结合IPF-PROM识别健康状态受损及可能伴抑郁症状的患者,并关注其生理与心理健康相关生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating lung disease which affects physical and mental well-being. The IPF Patient-Reported Outcome Measure (IPF-PROM) scale is a validated and reliable tool for the self-report of physical and psychological well-being in IPF. Aims and objectives This study aimed to validate a Greek version of the IPF-PROM scale and further investigate its correlation with clinical features of IPF patients and its interrelation with depressive symptoms and health-related quality of life (HRQoL). Methods This was a two-centre, observational, cross-sectional study, in which IPF patients completed three scales: IPF-PROM, Patient Health Questionnaire-9 (PHQ-9), an index of depressive symptoms, and Health Survey Questionnaire Short Form-12 (SF-12), an index of HRQoL, at the IPF Outpatient Clinics of two University Hospitals in Greece during 2023–2024. Logistic regression analysis was conducted to assess severe status of IPF-PROM compared with mild/moderate status. Results The study involved 136 IPF patients (87.9% males) with a mean age of 73.5±7.9 years. Patients were classified overall with moderate disease according to IPF-PROM mean scores (41.7±31.3), particularly in the combined Breathlessness/Fatigue and the Psychological well-being components (40.1 and 43.8, respectively, p>0.050). Patients with severe symptoms, as measured by IPF-PROM, scored higher levels of depressive symptoms on PHQ-9 compared with those with moderate or mild symptoms (17.1, 12.3 and 1.4, respectively, p<0.001) and lower levels of HRQoL in physical (32.6, 34.7 and 47.9, p<0.001) and mental health on SF-12 (23.9, 34.5 and 50.3, p<0.001). Patients with incrementally higher levels of oxygen saturation had lower odds for severe health status according to IPF-PROM (OR=0.83, p=0.018). Conclusions A significant percentage of IPF patients present with impaired health status and symptoms suggestive of depression. The IPF-PROM scale represents a useful tool that may predict impairment of mental health and HRQoL in IPF, with potential utility for clinical practice and research.
引用
- BMJ Open Respiratory Research:Application of the Idiopathic Pulmonary Fibrosis Patient-Reported Outcome Measure (IPF-PROM) scale to a Greek IPF patient population and its interrelation with depressive symptoms and health-related quality of life
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。